Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
JP Stock MarketDetailed Quotes
4751 CyberAgent
- 1077.0
- -7.5-0.69%
20min DelayNot Open Dec 11 15:30 JST
545.36BMarket Cap36.53P/E (Static)
1079.0High1061.5Low1.98MVolume1075.0Open1084.5Pre Close2.12BTurnover1136.052wk High0.49%Turnover Ratio506.37MShares797.552wk Low29.48EPS TTM433.15BFloat Cap2441.0Historical High36.53P/E (Static)402.18MShs Float10.6Historical Low29.48EPS LYR1.61%Amplitude16.00Dividend TTM3.37P/B100Lot Size1.49%Div YieldTTM
CyberAgent Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.50%803B | 9.95%215.13B | 15.22%193.08B | 1.36%720.21B | 5.11%185.23B | -0.24%171.74B | 2.38%195.66B | -2.05%167.58B | 6.62%710.58B | -1.95%176.23B |
| Cost of revenue | 10.36%582.47B | 11.91%149.57B | 11.42%143.06B | 7.40%527.8B | 10.35%135.29B | 5.28%130.48B | 4.24%133.65B | 10.04%128.39B | 13.11%491.42B | 6.00%122.6B |
| Gross profit | 14.62%220.52B | 5.73%65.56B | 27.64%50.02B | -12.21%192.4B | -6.86%49.95B | -14.44%41.26B | -1.40%62.01B | -27.99%39.19B | -5.53%219.16B | -16.30%53.63B |
| Operating expense | 6.45%178.68B | 2.94%44.49B | 8.14%43.73B | 11.87%167.85B | 9.77%44.36B | 5.21%39.83B | 16.29%43.22B | 16.84%40.44B | 17.58%150.04B | 8.64%40.41B |
| Operating profit | 70.40%41.84B | 12.15%21.07B | 600.40%6.29B | -64.47%24.56B | -57.70%5.59B | -86.16%1.44B | -26.96%18.79B | -106.34%-1.26B | -33.79%69.11B | -50.82%13.22B |
| Net non-operating interest income (expenses) | 100.00%124M | -60.00%14M | -143.75%-14M | -27.06%62M | -113.04%-3M | -110.00%-2M | 94.44%35M | 33.33%32M | -27.97%85M | -14.81%23M |
| Non-operating interest income | 95.24%369M | 43.75%69M | -4.55%42M | 35.97%189M | 57.14%55M | 20.00%42M | 45.45%48M | 22.22%44M | 2.96%139M | 0.00%35M |
| Non-operating interest expense | 92.91%245M | 323.08%55M | 366.67%56M | 135.19%127M | 383.33%58M | 193.33%44M | -13.33%13M | 0.00%12M | 217.65%54M | 50.00%12M |
| Net investment income | -150.82%-93M | 10.00%11M | 0.00%138M | -51.20%183M | -114.63%-6M | -76.70%41M | -50.00%10M | 0.00%138M | -23.63%375M | -75.60%41M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 161.74%71M | -128.40%-115M | 8,200.00%405M | |||||||
| Income from associates and other participating interests | -175.82%-251M | 30M | -46M | 70.93%-91M | 36.10%-200M | 109M | 0 | 0 | 0.32%-313M | -820.59%-313M |
| Special income (charges) | -343.44%-11.32B | -112.65%-1.93B | -481.96%-3.39B | 64.61%-2.55B | 54.13%-2.31B | 65.29%-218M | -37.94%-909M | 200.34%887M | -81.21%-7.21B | -51.81%-5.04B |
| Less:Impairment of capital assets | ---- | ---- | ---- | 203.57%170M | 18.92%44M | 131.58%44M | ---- | ---- | --56M | --37M |
| Less:Other special charges | 450.54%5.12B | -322.32%-1.33B | 365.54%3.21B | 259.25%930M | 138.70%1.39B | 114.03%150M | 809.52%596M | -7,966.67%-1.21B | 47.90%-584M | 62.22%584M |
| Less:Write off | 326.77%6.2B | 1,270.56%3.17B | -45.82%175M | -81.23%1.45B | -80.21%875M | -98.57%24M | -68.91%231M | -64.07%323M | 51.74%7.74B | 49.29%4.42B |
| Other non-operating income (expenses) | -8.52%451M | 233.73%277M | -20.14%115M | 42.49%493M | -33.99%235M | 1,450.00%31M | -29.66%83M | 210.77%144M | 1,053.33%346M | 394.21%356M |
| Income before tax | 36.81%30.83B | 8.55%19.54B | 6,042.31%3.09B | -64.12%22.53B | -63.30%3.19B | -85.96%1.4B | -28.62%18B | -100.27%-52M | -37.65%62.8B | -63.16%8.68B |
| Income tax | -12.16%10.18B | -12.66%5.7B | -10.66%3.28B | -50.45%11.59B | -75.08%735M | -85.83%652M | -22.20%6.53B | -50.63%3.68B | -31.32%23.39B | -62.56%2.95B |
| Net income | 88.66%20.65B | 20.58%13.84B | 94.82%-193M | -72.24%10.94B | -57.24%2.45B | -86.08%743M | -31.82%11.48B | -132.41%-3.73B | -40.88%39.41B | -63.46%5.74B |
| Net income continuous operations | 88.65%20.65B | 20.61%13.84B | 94.80%-194M | -72.23%10.94B | -57.24%2.45B | -86.06%744M | -31.82%11.48B | -132.40%-3.73B | -40.88%39.41B | -63.46%5.73B |
| Noncontrolling interests | -21.62%4.4B | -2.10%3.5B | -78.14%278M | -63.07%5.61B | -67.43%722M | -97.77%40M | -38.00%3.58B | -76.51%1.27B | -39.51%15.19B | -69.14%2.22B |
| Net income attributable to the company | 204.69%16.25B | 30.86%10.34B | 90.56%-472M | -77.98%5.33B | -50.82%1.73B | -80.15%704M | -28.60%7.9B | -182.12%-5B | -41.72%24.22B | -58.66%3.52B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 204.69%16.25B | 30.86%10.34B | 90.56%-472M | -77.98%5.33B | -50.82%1.73B | -80.15%704M | -28.60%7.9B | -182.12%-5B | -41.72%24.22B | -58.66%3.52B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 204.75%32.09 | 30.83%20.41 | 90.59%-0.93 | -78.01%10.53 | -50.79%3.42 | -80.17%1.39 | -28.70%15.6 | -181.99%-9.88 | -41.81%47.89 | -58.73%6.95 |
| Diluted earnings per share | 207.08%29.48 | 30.83%20.41 | 90.59%-0.93 | -78.82%9.6 | -50.38%3.26 | -83.38%1.1 | -24.82%15.6 | -186.74%-9.88 | -41.81%45.33 | -58.76%6.57 |
| Dividend per share | 6.67%16 | 0 | 0 | 7.14%15 | 7.14%15 | 0 | 0 | 0 | 40.00%14 | 40.00%14 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |